Epstein Secrets

value for the Company's equity. Please see Exhibits F and G for further details related to our analysis utilizing the Income Approach. • PCMMM of the Market Approach. This methodology was considered as a reasonableness check in our analysis, but ultimately not relied upon due to differences between the Company an

p.n.s min naS WIN • novsa ..tu Oren &shay iv itp• sampan.. or0soad r*v. steurtntestepotalm maw.. sisaTrionerat Me. Me *WMw tam, to sahistispne Walla fflaS PrAntlwagr.V 1004PaRilituparropretrom ANIS . Yl 5._sn Irv, *gm waa saveassao pig) I...Ml vosientsues (Sift (.1...0111.nemssao ( emi mlid0 wane's°. nacnou

value for the Company's equity. Please see Exhibits F and G for further details related to our analysis utilizing the Income Approach. • PCMMM of the Market Approach. This methodology was considered as a reasonableness check in our analysis, but ultimately not relied upon due to differences between the Company an

p.n.s min naS WIN • novsa ..tu Oren &shay iv itp• sampan.. or0soad r*v. steurtntestepotalm maw.. sisaTrionerat Me. Me *WMw tam, to sahistispne Walla fflaS PrAntlwagr.V 1004PaRilituparropretrom ANIS . Yl 5._sn Irv, *gm waa saveassao pig) I...Ml vosientsues (Sift (.1...0111.nemssao ( emi mlid0 wane's°. nacnou

value for the Company's equity. Please see Exhibits F and G for further details related to our analysis utilizing the Income Approach. • PCMMM of the Market Approach. This methodology was considered as a reasonableness check in our analysis, but ultimately not relied upon due to differences between the Company an

p.n.s min naS WIN • novsa ..tu Oren &shay iv itp• sampan.. or0soad r*v. steurtntestepotalm maw.. sisaTrionerat Me. Me *WMw tam, to sahistispne Walla fflaS PrAntlwagr.V 1004PaRilituparropretrom ANIS . Yl 5._sn Irv, *gm waa saveassao pig) I...Ml vosientsues (Sift (.1...0111.nemssao ( emi mlid0 wane's°. nacnou